Velbert, Germany

Dieter Lang

This inventor holds 67 USPTO granted patents and 26 published patent applications, plus 15 CIPO patents and 32 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D). Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh, Aicuris Gmbh + Co. Kg.. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Lang. Retrieved from https://idiyas.com/inventor/dieter-lang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 67 

% Patents Active = 29.9

 

 

Average Co-Inventor Count = 10.3

ph-index = 12

Forward Citations = 518(Granted Patents)

Forward Citations (Not Self Cited) = 430(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cardiopulmonary Disorders
Dihydroquinazolines
Oxopyridine Derivatives
Piperidinyl Tetrahydroquinolines
Azabicyclic Carbamates
Alpha-7 Nicotinic Receptors
Triazine Derivatives
Antiviral Agents
Dicarboxylic Acids
Phenyltriazole Derivatives
Rho Kinase Inhibitors
67 patents (USPTO):Explore Patents

Title: Dieter Lang: A Pioneering Inventor in the Field of Medicinal Innovations

Introduction:

Innovation is the driving force behind the advancement of industries and economies worldwide. One individual who has greatly contributed to the field of medicinal innovations is Dieter Lang, a prolific inventor hailing from Velbert, Germany. With an impressive number of patents to his name and a significant impact on the pharmaceutical industry, Dieter Lang has made remarkable contributions to the development of cutting-edge medications. This article will delve into his latest patents, career highlights, and collaborations, highlighting his remarkable journey as an inventor.

Latest Patents:

Dieter Lang's latest patents showcase his expertise in the field of medicinal chemistry and his commitment to improving healthcare treatments. Two notable patents are particularly worth mentioning:

1. Substituted Dihydroquinazolines: This patent focuses on substituted dihydroquinazolines and their use in the preparation of medicaments for the treatment and prevention of diseases, with a specific emphasis on antiviral agents targeting cytomegaloviruses.

2. Substituted Oxopyridine Derivatives: In this patent, Dieter Lang introduces substituted oxopyridine derivatives and their application in the production of medicaments for various ailments. These derivatives have shown promise in treating cardiovascular disorders, including thrombotic or thromboembolic disorders, oedemas, as well as ophthalmic disorders.

Career Highlights:

Dieter Lang has made a significant impact on the pharmaceutical industry throughout his successful career. His expertise has been honed through his association with prominent companies, including Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. These renowned companies have provided him with a platform to develop and showcase his inventions, further fueling the growth of cutting-edge medical treatments.

Collaborations:

Collaboration and the exchange of ideas are crucial factors for innovation. Dieter Lang has worked closely with esteemed colleagues, such as Frank Wunder and Johannes-Peter Stasch, who have undoubtedly played instrumental roles in supporting and enhancing his inventive endeavors. These collaborations have fostered an environment of shared knowledge, leading to groundbreaking advancements in medicinal innovations.

Conclusion:

Dieter Lang's contributions to the field of medicinal innovations have been invaluable. With an impressive repertoire of 66 patents, his inventions have paved the way for novel treatments and therapeutic approaches. Through his association with renowned companies and collaborations with esteemed colleagues, Dieter Lang has left an indelible mark on the pharmaceutical industry. His remarkable journey as an inventor continues to inspire future generations, emphasizing the power of innovation and patents in transforming healthcare landscapes worldwide.

Disclaimer: The information provided in this article is based on available data and is subject to verification and updates from reliable sources.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…